Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
TMCnet
10h
This Week in Health News: 11 Stories You Need to See
A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including the latest FDA approvals, ...
23h
FDA approves Ebglyss for moderate-to-severe atopic dermatitis
The U.S. Food and Drug Administration has approved Eli Lilly's Ebglyss (lebrikizumab-lbkz) for adults and children aged 12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Kentucky judge fatally shot
FCC chair denies Trump call
To visit US next week
Cancels appearance w/ Duda
Boy kills bear, saves father
Retires after 17 seasons
Man charged for threats
Hold campaign event in MI
To get a second moon
Ban called for in TX schools
Families lose appeal
Collapse hazard recall
Vows to remain in race
PGA welcomes LIV players
Joins Motion Picture Assn.
160M euros to Ukraine
NYC subway joyride arrest
Overdose deaths drop in US
Gun case sentencing delay
COVID, Wuhan market link
To receive Holbrooke award
FTC on privacy controls
EU warns Apple
Hails economic progress
Existing home sales drop
Dow, S&P hit record highs
Brazil threatens daily fines
Israel strikes Hezbollah
UN backs Palestine
US jobless claims fall
Makes MLB history
Related topics
Ebglyss
Atopic dermatitis
Food and Drug Administration
Eli Lilly
Feedback